Search for content, post, videos

Moberg Pharma launches new patent formulation

The company will start shipping a new patent pending formulation of Kerasal Nail to customers in the US.

According to Moberg Pharma the new product is shipped as a flow-through. It will be available at all existing retailers, including major drugstores CVS, Walgreens and Rite-Aid, mass retailers such as Walmart and Target as well as grocery chains such as Publix and Safeway. Current distribution of Kerasal Nail is estimated to more than 30 000 outlets in the U.S said Moberg Pharma in a statement.

The new formula is said to provide “benefits to consumers by improving user-friendliness, facilitating nail penetration and improving stability.” Moberg Pharma has applied for patent protection for the new product. The projected expiry date for this new IP is in 2034.

“I am very pleased to announce the launch of the improved formula. The new and improved Kerasal Nail™ demonstrates the value of our development approach, which continues to deliver innovative products with unique benefits to consumers. The new patent application can provide long term IP protection for our lead product”, said Peter Wolpert, CEO of Moberg Pharma AB.

Source: Moberg Pharma